Work for Adaptimmune Therapeutics?

Claim Your Profile

Adaptimmune Therapeutics Logo Image

Adaptimmune Therapeutics

Adaptimmune Therapeutics Banner Image

About Adaptimmune Therapeutics

201-500 Employees
Based in Abingdon, England

Adaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer. Their proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. They use these therapies to harness the body's own immune system to find and destroy diseased cells. Their SPEAR TCR therapies offer promise to patients that often have no other options. They are working hard to make that promise a reality.

Ticker:
ADAP
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol